Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-024396
Filing Date
2017-06-07
Accepted
2017-06-07 18:03:56
Documents
1
Period of Report
2017-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4169
  Complete submission text file 0001140361-17-024396.txt   5844
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
PARKER H STEWART (Reporting) CIK: 0001217456 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 17898237
SIC: 2836 Biological Products, (No Diagnostic Substances)